Hello team IXC. Peptron’s website notes their drug repositioning has indications for TBI. However, IXCs does also.
My knowledge of this is that in the acute phase of TBI pressure is a problem - hence would be under IXCs patent. Longer term however, TBI may be neurodegenerative - under peptrons.
Where this is remote from where we are now, it introduces an interesting juxtaposition.
Any thoughts? I would ask Tom but I’ll let the dust settle - obviously not something that will impact for a loooong time.
Hello team IXC. Peptron’s website notes their drug repositioning...
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
